Anzeige
Mehr »
Dienstag, 07.10.2025 - Börsentäglich über 12.000 News
Das Paradox-Becken beweist seine Stärke - und American Critical Minerals sitzt direkt darauf
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CN14 | ISIN: CA24463V1013 | Ticker-Symbol: DTC
Tradegate
07.10.25 | 07:30
0,482 Euro
+0,42 % +0,002
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
DEFENCE THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
DEFENCE THERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,4730,49808:04
0,4730,49908:00

Aktuelle News zur DEFENCE THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoDefence Therapeutics Inc.: Defence Therapeutics to Attend CPHI Worldwide in Frankfurt, October 28-30, 2025321Montreal, Quebec--(Newsfile Corp. - October 6, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in drug...
► Artikel lesen
DoDefence Therapeutics Inc: Defence names Lambermon as head of quality, operations23
DEFENCE THERAPEUTICS Aktie jetzt für 0€ handeln
DoDefence Therapeutics Inc.: Defence Therapeutics Appoints Dr. Mark Lambermon as Head of Quality and Operations376Montreal, Quebec--(Newsfile Corp. - October 2, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in drug...
► Artikel lesen
23.09.Defence Therapeutics Inc.: Defence's Director, Strategy & Business Advisor Dr. Amie Phinney Discusses the Accum Platform on Money Talk Radio with Ellis Martin685Montreal, Quebec--(Newsfile Corp. - September 23, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in...
► Artikel lesen
16.09.Defence Therapeutics Inc: Defence Therapeutics appoints Phinney as director36
16.09.Defence Therapeutics Inc.: Defence Therapeutics Appoints Dr. Amie Phinney as Director539Montreal, Quebec--(Newsfile Corp. - September 16, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in...
► Artikel lesen
16.09.Defence Therapeutics Inc: Defence Therapeutics closes debenture unit financing44
15.09.Defence Therapeutics Inc.: Defence Therapeutics Completes Fully Subscribed Debenture Units Financing of $2,000,000497Montreal, Quebec--(Newsfile Corp. - September 15, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specialized in...
► Artikel lesen
02.09.Defence Therapeutics Inc: Defence Therapeutics hires Phinney as business adviser30
02.09.Defence Therapeutics Inc.: Defence Therapeutics Engages Dr. Amie Phinney as Strategy & Business Advisor to Guide Next Phase of Growth1.114Montreal, Quebec--(Newsfile Corp. - September 2, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specialized in...
► Artikel lesen
23.08.Defence Therapeutics Inc: Defence arranges $1.2-million debenture unit offering109
23.08.Defence Therapeutics Inc.: Defence Therapeutics Announces Debenture Units Financing1.145Montreal, Quebec--(Newsfile Corp. - August 22, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specialized in drug...
► Artikel lesen
14.07.Defence Therapeutics Inc: Defence continues Accum ADC, radiopharma programs122
14.07.Defence Therapeutics Inc.: Defence's Accum Technology with ADC and Radiopharmaceutical Programs Target Cancer892Montreal, Quebec--(Newsfile Corp. - July 14, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specializing in drug...
► Artikel lesen
09.06.Defence Therapeutics Inc: Defence receives USPTO allowance for patent application88
09.06.Defence Therapeutics sichert sich US-Patent für bahnbrechende ADC-Technologie161
09.06.Defence Therapeutics Inc.: Defence Therapeutics Receives USPTO Allowance for Patent Application Covering Next-Gen ADC Technology686Montreal, Quebec--(Newsfile Corp. - June 9, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specializing in drug...
► Artikel lesen
02.06.Defence Therapeutics Inc: Defence Therapeutics opens first U.S. laboratory79
02.06.Defence Therapeutics Inc.: Defence Therapeutics Opens U.S. Laboratory in Boston-Cambridge Biotech Hub624Montreal, Quebec--(Newsfile Corp. - June 2, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specializing in advanced...
► Artikel lesen
28.05.Defence Therapeutics Inc.: Defence Therapeutics to Attend Bio International Convention in Boston, June 2025736Montreal, Quebec--(Newsfile Corp. - May 28, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing advanced...
► Artikel lesen
Weiter >>
52 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,3,14